Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial‐IRON Trial

Background Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. The aim of this study was to examine changes in myocardial iron content after FCM adm...

Full description

Bibliographic Details
Main Authors: Julio Núñez, Gema Miñana, Ingrid Cardells, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Luis Almenar, Maria P. López‐Lereu, Jose V. Monmeneu, Martina Amiguet, Jessika González, Alicia Serrano, Vicente Montagud, Raquel López‐Vilella, Ernesto Valero, Sergio García‐Blas, Vicent Bodí, Rafael de la Espriella‐Juan, Josep Lupón, Jorge Navarro, José Luis Górriz, Juan Sanchis, Francisco J. Chorro, Josep Comín‐Colet, Antoni Bayés‐Genís
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014254